Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19

被引:5
|
作者
Habermann, Elizabeth B. [1 ]
Tande, Aaron J. [2 ]
Pollock, Benjamin D. [3 ]
Neville, Matthew R. [3 ]
Ting, Henry H. [1 ,2 ,3 ,4 ]
Sampathkumar, Priya
机构
[1] Mayo Clin, Div Hlth Care Delivery Res, Rochester, MN 55902 USA
[2] Mayo Clin, Div Infect Dis, Rochester, MN USA
[3] Mayo Clin, Dept Qual Experience & Affordabil, Rochester, MN USA
[4] Mayo Clin, Dept Cardiovasc Med, Jacksonville, FL USA
来源
关键词
D O I
10.1017/ice.2021.38
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: We evaluated the risk of patients contracting coronavirus disease 2019 (COVID-19) during their hospital stay to inform the safety of hospitalization for a non-COVID-19 indication during this pandemic. Methods: A case series of adult patients hospitalized for 2 or more nights from May 15 to June 15, 2020 at large tertiary-care hospital in the midwestern United States was reviewed. All patients were screened at admission with the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test. Selected adult patients were also tested by IgG serology. After dismissal, patients with negative serology and PCR at admission were asked to undergo repeat serologic testing at 14-21 days after discharge. The primary outcome was healthcare-associated COVID-19 defined as a new positive SARS-CoV-2 PCR test on or after day 4 of hospital stay or within 7 days of hospital dismissal, or seroconversion in patients previously established as seronegative. Results: Of the 2,068 eligible adult patients, 1,778 (86.0%) completed admission PCR testing, while 1,339 (64.7%) also completed admission serology testing. Of the 1,310 (97.8%) who were both PCR and seronegative, 445 (34.0%) repeated postdischarge serology testing. No healthcare-associated COVID-19 cases were detected during the study period. Of 1,310 eligible PCR and seronegative adults, no patients tested PCR positive during hospital admission (95% confidence interval [CI], 0.0%-0.3%). Of the 445 (34.0%) who completed postdischarge serology testing, no patients seroconverted (0.0%; 95% CI, 0.0%-0.9%). Conclusion: We found low likelihood of hospital-associated COVID-19 with strict adherence to universal masking, physical distancing, and hand hygiene along with limited visitors and screening of admissions with PCR.
引用
收藏
页码:1479 / 1485
页数:7
相关论文
共 50 条
  • [21] Coronavirus disease 2019 (COVID-19) and Long COVID
    Chang, Yoon-Seok
    ASIA PACIFIC ALLERGY, 2022, 12 (02)
  • [22] Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital
    Oncul, Hasan
    Oncul, Fatma Y.
    Alakus, Mehmet F.
    Caglayan, Mehtap
    Dag, Umut
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1126 - 1132
  • [23] Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series
    Calvi, Emiliano
    Bernardi, Nicola
    Cimino, Giuliana
    Pascariello, Greta
    Faggiano, Pompilio
    Gavazzi, Emanuele
    Vizzardi, Enrico
    Metra, Marco
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (02)
  • [24] Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis
    Beckerman, Jennifer Kate
    Alarfaj, Mohammad
    Tracy, Cynthia M.
    Faiwiszewski, Ariel D.
    Choi, Andrew D.
    BMJ CASE REPORTS, 2021, 14 (05)
  • [25] Telemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A Neurosurgical Perspective
    Blue, Rachel
    Yang, Andrew, I
    Zhou, Cecilia
    De Ravin, Emma
    Teng, Clare W.
    Arguelles, Gabriel R.
    Huang, Vincent
    Wathen, Connor
    Miranda, Stephen P.
    Marcotte, Paul
    Malhotra, Neil R.
    Welch, William C.
    Lee, John Y. K.
    WORLD NEUROSURGERY, 2020, 139 : 549 - 557
  • [26] The management of coronavirus disease 2019 (COVID-19)
    Liu, Jialin
    Liu, Siru
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1484 - 1490
  • [27] Smoking and coronavirus disease 2019 (COVID-19)
    Underner, M.
    Peiffer, G.
    Perriot, J.
    Jaafari, N.
    REVUE DES MALADIES RESPIRATOIRES, 2020, 37 (05) : 433 - 436
  • [28] Resolution of coronavirus disease 2019 (COVID-19)
    Habas, Khaled
    Nganwuchu, Chioma
    Shahzad, Fanila
    Gopalan, Rajendran
    Haque, Mainul
    Rahman, Sayeeda
    Majumder, Anwarul Azim
    Nasim, Talat
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (12) : 1201 - 1211
  • [29] Having Coronavirus Disease 2019 (COVID-19)
    Shapiro, Janet M.
    JAMA CARDIOLOGY, 2020, 5 (10) : 1091 - 1091
  • [30] The Pandemic of Coronavirus Disease 2019 (COVID-19)
    Rashid, Nurshamimi Nor
    CURRENT MOLECULAR MEDICINE, 2022, 22 (09) : 761 - 765